AC
CBST

Apex Capital’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Apex Capital’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-57,000
Closed -$3.78M – 69
2014
Q3 		$3.78M Buy
+57,000
New +$3.74M 0.27% 54

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Apex Capital's CBST Position: Q4 2014 in Review

Apex Capital sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 57,000 shares — an estimated $3.78M sold.

Apex Capital first reported a position in CBST in Q3 2014 and held it in 1 quarter. The position peaked at $3.78M in Q3 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Apex Capital reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Apex Capital sold 57,000 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $3.78M.
  • Apex Capital first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2014 and held it in 1 quarter.
  • Apex Capital's CUBIST PHARMACEUTICALS INC position peaked at $3.78M in Q3 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Apex Capital's 13F filing for Q4 2014, filed 5 Feb 2015.